http://jcps.bjmu.edu.cn

Journal of Chinese Pharmaceutical Sciences ›› 2017, Vol. 26 ›› Issue (11): 847-849.

• Others • Previous Articles     Next Articles

International Symposium on Frontiers of Natural and Biomimetic Drugs---Innovations on Drugs Driven by the Integration of Chemical Biology

Tao Liu, Suwei Dong, Zhenjun Yang*, Lixin Yang, Zhu Guan   

  1. State Key Laboratory of Natural and Biomimetic Drugs
  • Received:2017-11-21 Revised:2017-11-23 Online:2017-11-30 Published:2017-11-25

RichHTML

0

PDF (PC)

73

Abstract:

Advances in Science and Technology in the past few decades have led to a significant expansion of our knowledge about human health and disease. Today, there have never been such great needs for multidisciplinary researchers to come together and address the complex challenges in human health. State Key Laboratory of Natural and Biomimetic Drugs (SKLNBD) in Peking University, is one of the first state key laboratories established in China. There are multi-disciplinary researches in SKLNBD, including Chemistry, Biology and Pharmacy, with a main interest and long-term goal of innovative drug discovery. The primary focus of the laboratory is on both fundamental and applied research on natural and biomimetic drugs, including nucleic acids, proteins, carbohydrates, synthetic/natural products, and trace elements to help tackle major diseases, such as tumor, cardio-cerebrovascular disease, mental illness and virus infection, etc. 

Key words: International Symposium on Frontiers of Natural and Biomimetic Drugs, Innovations on Drugs Driven by the Integration of Chemical Biology

Supporting:

About Journal | Info for Authors | Statements | Peer Review Policy | Submission | Copyright Info
京ICP备05051953号-7
Copyright © Journal of Chinese Pharmaceutical Sciences, School of Pharmaceutical Sciences, Peking University
Tel./Fax: +86-10-82801713, E-mail: jcps@bjmu.edu.cn
Powered by Beijing Magtech Co., Ltd.